Costa I, Pajon R and Granoff DM. Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding. mBio 2014;5:e01625-14.
Shaughnessy J, Vu DM, Punjabi R, Serra-Pladevall J, DeOliveira RB, Granoff DM, and Ram S. Fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an antibacterial immunotherapeutic. Clinical Vaccine and Immunology 2014;21:1452-1459. PubMed ID: 25143339.
Rossi R, Granoff DM, and Beernink PT. Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice. Vaccine, 2013; 31:5451-7. PubMed ID: 24035433.
Konar M, Granoff DM, Beernink PT. Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines. Journal of Infectious Diseases, 2013; June 26, Epub. PubMed ID: 23715659.
Pajon R, Fergus AM, and Granoff DM. Mutant native outer membrane vesicles combined with a serogroup A polysaccharide conjugate vaccine for prevention of meningococcal epidemics in Africa. PLoS One, 2013; 8:e66536. PubMed ID: 23805230.
Giuntini S, Vu DM, and Granoff DM. fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations. Vaccine, 2013; June 17, Epub. PubMed ID: 23791680.
Granoff DM, Ram S, and Beernink PT. Does binding of complement factor H to the meningococcal vaccine antigen, factor H-binding protein, decrease protective serum antibody responses? Clinical and Vaccine Immunology, 2013; June 5, Epub. PubMed ID: 23740919.
Granoff DM. Portrait: Coincidences, convergences and opportunities. Human Vaccines and Immunotherapeutics, 2013; 9:945-49. PubMed ID: 23807081.
Granoff DM. Commentary: European Medicines Agency recommends approval of a broadly protective vaccine against serogroup B meningococcal disease. Pediatric Infectious Disease Journal, 2013; 32:372-73. PubMed ID: 23263177.
Beernink PT, Shaughnessy J, Pajon R, Braga EM, Ram S, and Granoff DM. The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein. PLoS Pathogens, 2012; 8:e1002688. PubMed ID: 22589720.
Vu DM, Pajon R, Reason DC, and Granoff DM. A broadly cross-reactive monoclonal antibody against an epitope on the N-terminus of meningococcal fHbp. Scientific Reports, 2012; 2:341. PubMed ID: 22461972.
Giuntini S, Beernink PT, Reason DC, and Granoff DM. Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity. PLoS One, 2012; 7:e34272. PubMed ID: 22461909.
Vu DM, Shaughnessy J, Lewis LA, Ram S, Rice PA, and Granoff DM. Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis. Infection and Immunity, 2012; 80:643-50. PubMed ID: 22104107.
Giuntini S, Reason DC, and Granoff DM. Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density on bactericidal activity of antibodies to meningococcal factor H binding protein. Infection and Immunity, 2012; 80:187-94. PubMed ID: 22064712.
Granoff DM and Gilsdorf JR. Neisseria meningitidis (Meningococcus). In: Kliegman RM, Stanton B, St. Geme J, Schor N, and Behrman RE, editors. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Saunders Elsevier; 2012. p 929-935.
Revised: Tuesday, November 25, 2014 3:40 PM